Alterations in behavior, amyloid p‐42, caspase‐3, and Cox‐2 in mutant PS2 transgenic mouse model of Alzheimer's disease
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) occurs when neurons in the memory and cognition regions of the brain are accompanied by an accumulation of the long amyloid p‐proteins of the 39 to 43 amino acids derived from the amyloid precursor protein (APP) by cleavage with p‐and γ‐secretase. An increased production of Ap‐42 by mutation of PS2 genes promotes caspase expression and is associated with the Cox‐2 found in the brain of AD patients. To address this question in vivo, we expressed the human mutant PS2 (hPS2m ) (N141I) as well as wild PS2 (hPS2w) as a control in transgenic (Tg) mice under control of the neuron‐specific enolase ( NSE ) promoter. Water maze tests were used to demonstrate the behavioral defect; dot blot, Western blot, and immunohistochemical analyses were performed on the brain with the hPS2, Ap‐42, caspase‐3, and Cox‐2 antibody. We concluded that 1) Tg mice showed a behavioral dysfunction in the water maze test, 2) levels of hPS2, Ap‐42, caspase‐3, and Cox‐2 expression were modulated in the brains of both Tg mice, 3) dense staining with antibody to hPS2, Ap‐42, caspase‐3, and Cox‐2 was visible in the brains of Tg mice compared with age‐matched control mice, and 4) distinguishable AD phenotypes between hPS2w‐and hPS2m‐Tg mice did not appear. These results suggest that an elevation of Ap‐42 by overexpression of hPS2 and mutation of hPS2m might induce the behavioral deficit and caspase‐3 and Cox‐2 induction, which could be useful in the therapeutic testing of compounds to have considerable clinical effects.—Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y., Hong, J. T., Song, C. W., Paik, S. G., Cho, J. S., Kim, Y. K. Alterations in behavior, amyloid p‐42, caspase‐3, and Cox‐2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 16, 805–813 (2002)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“( -APP) (2), PS-1 (3), PS-2 (4), and apolipoprotein E”
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 8×
“At least four gene mutations are linked to the early onset of AD including the -amyloid precursor protein ( -APP) (2), PS-1 (3), PS-2 (4), and apolipoprotein E type 4 (APOE-E4) (5, 6).”
BackgroundInfluentialScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 6×
“At least four gene mutations are linked to the early onset of AD including the -amyloid precursor protein ( -APP) (2), PS-1 (3), PS-2 (4), and apolipoprotein E type 4 (APOE-E4) (5, 6).”
InfluentialRAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 1×
“Increased A might induce apoptotic activity by interacting with neuronal receptors, including the receptor for advanced glycation end-products (RAGE) (20), the p75 neurotrophin receptor (21), and the APP (22).”
BackgroundArnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520 · cited 2×
“Increased A might induce apoptotic activity by interacting with neuronal receptors, including the receptor for advanced glycation end-products (RAGE) (20), the p75 neurotrophin receptor (21), and the APP (22).”
Background
Cited by
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Eimer, W. A., & Vassar, R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-2 · Cited by 425
“For example, activated Caspase-3 immunoreactivity has been reported to be present in AD brain [41,42] and in APP transgenic mice [43,44].”
BackgroundInflammation and Alzheimer’s disease
Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396
Self-citationPhospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Sanchez-Mejia, R. O., Newman, J. W., Toh, S., Yu, G.-Q., Zhou, Y., Halabisky, B., Cissé, M., Scearce-Levie, K., Cheng, I. H., Gan, L., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2213 · Cited by 369
Mouse models of Alzheimer's disease
Hall, A. M., & Roberson, E. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.017 · Cited by 317
Chen, X.-H., Siman, R., Iwata, A., Meaney, D. F., Trojanowski, J. Q., & Smith, D. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63303-2 · Cited by 271
Lee, J. W., Lee, Y. K., Ban, J. O., Ha, T. Y., Yun, Y. P., Han, S. B., Oh, K. W., & Hong, J. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.109785 · Cited by 269
Self-citationBadshah, H., Ali, T., & Kim, M. O. (2016) · Scientific Reports · doi:10.1038/srep24493 · Cited by 217
Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease
Horowitz, P. M., Patterson, K. R., Guillozet-Bongaarts, A. L., Reynolds, M. R., Carroll, C. A., Weintraub, S. T., Bennett, D. A., Cryns, V. L., Berry, R. W., & Binder, L. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1988-04.2004 · Cited by 215
Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.021 · Cited by 69
Self-citationExercise-Induced Modulation of Neuroinflammation in Models of Alzheimer’s Disease
Kelly, Á. M. (2018) · Brain Plasticity · doi:10.3233/bpl-180074 · Cited by 55
MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice.
Li, J., Li, D., Zhou, H., Wu, G., He, Z., Liao, W., Li, Y., & Zhi, Y. (2020) · Aging · doi:10.18632/aging.104005 · Cited by 35
“For example, Caspase-3 immunoreactivity was activated in AD brain [42, 44] and in APP/PS1 mice [45, 46].”
BackgroundZhu, X., Hatfield, J., Sullivan, J. K., Xu, F., & Van Nostrand, W. E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01755-y · Cited by 33
Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis
Podder, A., Pandit, M., & Narayanan, L. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2018.0131 · Cited by 14
“The peptide fragment builds up in the brain and forms clumps called amyloid plaques that are characteristic of AD (Grueninger et al., 2010; Hwang et al., 2002; Ozmen et al., 2009; Richards et al., 2003; Walker et al., 2005).”
Ma, E.-H., Rathnayake, A. U., Lee, J. K., Lee, S.-M., & Byun, H.-G. (2021) · European Food Research and Technology · doi:10.1007/s00217-021-03770-6 · Cited by 8
Metadata
- Authors
- Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y., Hong, J. T., Song, C. W., Paik, S. G., Cho, J. S., & Kim, Y. K.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-06
- Volume
- 16
- Issue
- 8
- Pages
- 805-813
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2106083328
- Cited by
- 147
- References
- 9
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.